摘要
目的探讨OAS-1基因SNP rs10774671与慢性HBV感染者自发性HBeAg血清转换的关系。方法收集慢性HBV感染者HBeAg阳性组58例、anti—HBe阳性组68例和无HBV感染对照组72例的外周血,进行DNA提取扩增,再用竞争分化聚合酶链反应方法扩增,结合酶免疫显色检测该SNP的基因型,组间差异进行分析比较。结果HBeAg阳性组的基因型GG+GA比例为31.0%、等位基因G频率为16.4%,而anti-HBe阳性组为48.5%、29.4%,对照组为50.0%、28.4%;HBeAg阳性组与anti-HBe阳性组或对照组之问的差异均有统计学意义,而anti-HBe阳性组与对照组之间的差异无统计学意义。结论SNP rs10774671等位基因G可能有助于慢性HBV感染者发生自发性HBeAg血清转换,其基因型检测对于慢性HBV感染者干扰素治疗有一定的预测价值。
Objective To investigate the relationship between the SNP rs10774671 on OAS-1 gene and spontaneous HBeAg seroconversion in chronic HBV infection. Methods Blood samples were collected from 58 HBeAg positive, 68 anti-HBe positive patients with chronic HBV infection, and 72 normal control cases without HBV infection. Chromosomal DNA was extracted and OAS-1 gene was amplified. SNP genotyping was performed with the competitively differentiated polymerase chain reaction and enzyme immunoassay. Results In HBeAg positive group, frequencies of genotype GG plus GA and allele G were 31.0% and 16.4%. They were 48.5% and 29.4% in anti-HBe positive group, and 50.0% and 28.4% in normal control group respectively . Differences between HBeAg positive group and anti-HBe positive group or normal control group were statistically significant. But they weren't between anti-HBe positive group and normal control group. Conclusion Allele G on SNP rs10774671 of OAS-1 gene maybe benefits patients with chronic HBV infection to achieve spontaneous HBeAg seroconversion. Genotyping on this SNP may be predicting valuable for interferon therapy for chronic HBV infection.
出处
《中华实验和临床病毒学杂志》
CAS
CSCD
北大核心
2009年第1期35-37,共3页
Chinese Journal of Experimental and Clinical Virology
基金
广东省自然科学基金重点项目(06104609)